Asthma Management in Pediatric Patients

Introduction

Asthma management in pediatric patients involves a comprehensive approach, including diagnosis, treatment, and monitoring, as recommended by the American Academy of Allergy, Asthma, and Immunology 1, 2

The recommended dose of nebulized salbutamol for pediatric patients is 2.5 mg for children weighing less than 20 kg and 5 mg for children weighing 20 kg or more, as recommended by the American Society of Anesthesiologists 3
For acute asthma, nebulized salbutamol can be administered every 4-6 hours if improving, and for severe symptoms, it can be repeated every 30 minutes if not improving, with a strength of evidence based on clinical guidelines from the British Thoracic Society 4
The recommended dose of nebulized levosalbutamol for pediatric patients is 0.075 mg/kg (minimum dose 1.25 mg) every 20 minutes for 3 doses, then 0.075-0.15 mg/kg every 1-4 hours as needed, according to the American Academy of Allergy, Asthma, and Immunology 1
Albuterol dosage is 0.15 mg/kg (minimum dose 2.5 mg) every 20 minutes for 3 doses, then 0.15-0.3 mg/kg up to 10 mg every 1-4 hours as needed, or 0.5 mg/kg/hour by continuous nebulization for pediatric patients with asthma, as recommended by the American Academy of Allergy, Asthma, and Immunology 2
Levalbuterol (R-albuterol) can be administered at half the mg dose of albuterol with comparable efficacy and safety, with a recommended dose of 0.075 mg/kg (minimum dose 1.25 mg) every 20 minutes for 3 doses, then 0.075-0.15 mg/kg up to 5 mg every 1-4 hours as needed 2
MDI dosing is 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed, according to the American Academy of Allergy, Asthma, and Immunology 1, 2

For mild episodes of asthma, a hand-held inhaler (200-400 μg) can be considered, while for moderate episodes, either a hand-held inhaler (400 μg) or nebulizer can be used, as suggested by the National Asthma Education and Prevention Program 4
For severe episodes of asthma, nebulized treatment with oxygen is preferred, and in severe cases, consider adding ipratropium bromide (250-500 μg) to the nebulizer solution for enhanced bronchodilation, based on recommendations from the Global Initiative for Asthma 4
For children under 6 with an upper respiratory infection, nebulized salbutamol is particularly beneficial to administer before general anesthesia, according to the American Academy of Pediatrics 3
The British Thoracic Society categorizes asthma severity as mild-moderate (respiratory rate <50/min, pulse <140/min), severe (too breathless to feed, respiratory rate >50/min, pulse >140/min), or life-threatening (cyanosis, silent chest, poor respiratory effort, agitation or reduced consciousness) 5

Monitor for clinical response (improvement in respiratory rate, work of breathing), and maintain oxygen saturation (SaO₂ >92%) 5
For severe symptoms, the British Thoracic Society recommends giving high-flow oxygen via face mask, administering salbutamol 2.5 mg via oxygen-driven nebulizer, and considering adding ipratropium 100 μg nebulized every 6 hours 5
If improving, continue salbutamol nebulization every 4 hours and consider oral prednisolone 1-2 mg/kg daily (maximum 40 mg) 5
Schedule a follow-up appointment with a primary care provider or asthma specialist within 1-4 weeks after an acute exacerbation, as recommended by the American Academy of Allergy, Asthma, and Immunology 1
Assess for potential triggers, including environmental allergens (dust mites, pet dander), recent respiratory infections, exercise-induced symptoms, weather changes, and indoor air quality issues, as recommended by the American Academy of Allergy, Asthma, and Immunology 6, 7

For mild persistent asthma: low-dose inhaled corticosteroid (ICS) is the preferred controller, as recommended by the American Academy of Allergy, Asthma, and Immunology 6
For moderate persistent asthma: consider step-up options, according to the American Academy of Allergy, Asthma, and Immunology 6, 8
Combination ICS-LABA therapy provides better control than increasing ICS dose alone in children ≥4 years, as recommended by the American Academy of Allergy, Asthma, and Immunology 8
For children ≥4 years: consider adding long-acting beta-agonist (LABA) to ICS, as recommended by the American Academy of Allergy, Asthma, and Immunology 8
For children <4 years: consider adding leukotriene receptor antagonist (LTRA) like montelukast, according to the American Academy of Allergy, Asthma, and Immunology 6

Provide a written asthma action plan for future exacerbations, as recommended by the British Thoracic Society 5
Check inhaler technique with both devices, verify dosing frequency and timing, and assess understanding of maintenance vs. rescue medication use, according to the American Academy of Allergy, Asthma, and Immunology 6
Ensure proper use of spacers and valved holding chambers, and provide education on asthma self-management, as recommended by Pediatrics 9

Monitor for tachycardia and tremors with increased albuterol use, and be aware of potential hypokalemia with repeated beta-agonist dosing, although the specific monitoring recommendations are not provided in the cited references 2
For systemic corticosteroids: monitor for short-term effects like increased appetite, mood changes, and sleep disturbances, as recommended by the American Academy of Allergy, Asthma, and Immunology 2
For long-term ICS: monitor growth velocity, according to the American Academy of Allergy, Asthma, and Immunology 6